NYU Ovarian Cancer Early Detection Program Blood and Genetics
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00531778|
Recruitment Status : Terminated (insufficient funding and resource)
First Posted : September 19, 2007
Last Update Posted : January 11, 2011
|Condition or disease|
The aim of NYU Ovarian Cancer Early Detection Program is to establish an effective, early detection program employing state-of-the-art science and technology in collaboration with other nationally recognized clinicians and scientists.
This proposed research study will foster collaboration between clinicians and scientists that will facilitate the rapid identification of a set of molecular, biochemical, functional, and genetic markers which can be employed to effectively detect and manage ovarian cancer and other gynecological malignancies.
|Study Type :||Observational|
|Actual Enrollment :||890 participants|
|Official Title:||NYU Ovarian Cancer Early Detection Program Blood and Genetics|
|Study Start Date :||June 2004|
|Actual Study Completion Date :||November 2010|
|NYU OCEDP Population|
- identification and development of highly sensitive and specific tumor markers for ovarian cancer [ Time Frame: 5 years ]
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00531778
|United States, New York|
|NYUCancer Institute Clinical Cancer Center|
|New York, New York, United States, 10016|
|Principal Investigator:||Bhavana Pothuri, M.D.||NYU Langone Health|